Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Increased RHAMM expression relates to ovarian cancer progression.

Buttermore ST, Hoffman MS, Kumar A, Champeaux A, Nicosia SV, Kruk PA.

J Ovarian Res. 2017 Sep 27;10(1):66. doi: 10.1186/s13048-017-0360-1.

2.

MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.

Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA, Cheng JQ.

J Biol Chem. 2016 Oct 21;291(43):22851. No abstract available.

3.

BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells.

Woolery KT, Mohamed M, Linger RJ, Dobrinski KP, Roman J, Kruk PA.

Biomed Res Int. 2015;2015:652017. doi: 10.1155/2015/652017. Epub 2015 Aug 19.

4.

Urinary interleukin-1β levels among gynecological patients.

Woolery KT, Hoffman MS, Kraft J, Nicosia SV, Kumar A, Kruk PA.

J Ovarian Res. 2014 Nov 18;7:104. doi: 10.1186/s13048-014-0104-4.

5.

Procurement and cytological features of human fallopian tube fimbrial cells by ex vivo imprinting and washing.

Dobrinski K, Esposito NN, Kruk PA, Wenham R, Hoffman M, Coppola D, Bai W, Zhang X, Siddique N, Nicosia SV.

J Am Soc Cytopathol. 2014 Nov - Dec;3(6):309-318. doi: 10.1016/j.jasc.2014.07.002. Epub 2014 Jul 23.

PMID:
31051721
6.

MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.

Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA, Cheng JQ.

J Biol Chem. 2012 Oct 12;287(42):34970-8. doi: 10.1074/jbc.M112.374611. Epub 2012 Aug 27. Retraction in: J Biol Chem. 2016 Oct 21;291(43):22851.

7.

Ovarian epithelial-stromal interactions: role of interleukins 1 and 6.

Woolery KT, Kruk PA.

Obstet Gynecol Int. 2011;2011:358493. doi: 10.1155/2011/358493. Epub 2011 Jun 26.

8.

BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications.

Linger RJ, Kruk PA.

FEBS J. 2010 Aug;277(15):3086-96. doi: 10.1111/j.1742-4658.2010.07735.x. Epub 2010 Jul 1. Review.

9.

Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer.

Drenberg CD, Saunders BO, Wilbanks GD, Chen R, Nicosia RF, Kruk PA, Nicosia SV.

Gynecol Oncol. 2010 Apr;117(1):117-24. doi: 10.1016/j.ygyno.2009.12.011. Epub 2010 Jan 13.

PMID:
20071014
10.

Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues.

Drenberg CD, Livingston S, Chen R, Kruk PA, Nicosia SV.

Obstet Gynecol Int. 2009;2009:730739. doi: 10.1155/2009/730739. Epub 2009 Nov 1.

11.

BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells.

O'Donnell JD, Linger RJ, Kruk PA.

Gynecol Oncol. 2010 Feb;116(2):262-8. doi: 10.1016/j.ygyno.2009.10.052. Epub 2009 Nov 10.

PMID:
19906413
12.

Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation.

Anderson NS, Turner L, Livingston S, Chen R, Nicosia SV, Kruk PA.

J Ovarian Res. 2009 Oct 25;2:16. doi: 10.1186/1757-2215-2-16.

13.

Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer.

Guo JP, Shu SK, He L, Lee YC, Kruk PA, Grenman S, Nicosia SV, Mor G, Schell MJ, Coppola D, Cheng JQ.

Am J Pathol. 2009 Jul;175(1):324-33. doi: 10.2353/ajpath.2009.080767. Epub 2009 Jun 4.

14.

A case study of "disorganized development" and its possible relevance to genetic determinants of aging.

Walker RF, Pakula LC, Sutcliffe MJ, Kruk PA, Graakjaer J, Shay JW.

Mech Ageing Dev. 2009 May;130(5):350-6. doi: 10.1016/j.mad.2009.02.003. Epub 2009 Feb 24.

PMID:
19428454
15.

Urinary levels of Bcl-2 are elevated in ovarian cancer patients.

Anderson NS, Bermudez Y, Badgwell D, Chen R, Nicosia SV, Bast RC Jr, Kruk PA.

Gynecol Oncol. 2009 Jan;112(1):60-7. doi: 10.1016/j.ygyno.2008.09.037. Epub 2008 Nov 12.

16.

Deacetylation of cortactin by SIRT1 promotes cell migration.

Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, Kruk PA, Cheng JQ, Bai W, Chen J, Nicosia SV, Zhang X.

Oncogene. 2009 Jan 22;28(3):445-60. doi: 10.1038/onc.2008.388. Epub 2008 Oct 13.

PMID:
18850005
17.

BRCA1 185delAG truncation protein, BRAt, amplifies caspase-mediated apoptosis in ovarian cells.

O'Donnell JD, Johnson NC, Turbeville TD, Alfonso MY, Kruk PA.

In Vitro Cell Dev Biol Anim. 2008 Sep-Oct;44(8-9):357-67. doi: 10.1007/s11626-008-9122-0. Epub 2008 Jul 2.

PMID:
18594935
18.

Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.

Bermudez Y, Yang H, Cheng JQ, Kruk PA.

Growth Factors. 2008 Feb;26(1):1-11. doi: 10.1080/08977190802001389.

PMID:
18365874
19.

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.

Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ.

Cancer Res. 2008 Jan 15;68(2):425-33. doi: 10.1158/0008-5472.CAN-07-2488. Erratum in: Cancer Res. 2008 Mar 1;68(5):1609.

20.

Telomerase confers resistance to caspase-mediated apoptosis.

Bermudez Y, Erasso D, Johnson NC, Alfonso MY, Lowell NE, Kruk PA.

Clin Interv Aging. 2006;1(2):155-67.

21.

VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent.

Bermudez Y, Yang H, Saunders BO, Cheng JQ, Nicosia SV, Kruk PA.

Gynecol Oncol. 2007 Sep;106(3):526-37. Epub 2007 Jun 8.

PMID:
17559911
22.

Vitamin E suppresses telomerase activity in ovarian cancer cells.

Bermudez Y, Ahmadi S, Lowell NE, Kruk PA.

Cancer Detect Prev. 2007;31(2):119-28. Epub 2007 Feb 28.

PMID:
17335992
23.

The genesis of RNA interference, its potential clinical applications, and implications in gynecologic cancer.

Tebes SJ, Kruk PA.

Gynecol Oncol. 2005 Dec;99(3):736-41. Epub 2005 Sep 27. Review.

PMID:
16194565
24.
25.

Cytology of human ovarian surface epithelial brushings.

Nicosia SV, Wilbanks GD, Saunders B, Mayer J, Cardosi RJ, Kruk PA, Cheng J, Bai W, Coppola D, Fiorica J.

Cancer. 2004 Feb 25;102(1):1-10.

26.

Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells.

Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA, Cheng JQ.

Cancer Res. 2004 Jan 15;64(2):463-7.

28.

Oncogenic pathways implicated in ovarian epithelial cancer.

Nicosia SV, Bai W, Cheng JQ, Coppola D, Kruk PA.

Hematol Oncol Clin North Am. 2003 Aug;17(4):927-43. Review.

PMID:
12959183
29.
30.

Telomerase is regulated by c-Jun NH2-terminal kinase in ovarian surface epithelial cells.

Alfonso-De Matte MY, Yang H, Evans MS, Cheng JQ, Kruk PA.

Cancer Res. 2002 Aug 15;62(16):4575-8.

31.

Calcium-mediated telomerase activity in ovarian epithelial cells.

Alfonso-De Matte MY, Moses-Soto H, Kruk PA.

Arch Biochem Biophys. 2002 Mar 15;399(2):239-44.

PMID:
11888211
32.

Ultraviolet irradiation- and dimethyl sulfoxide-induced telomerase activity in ovarian epithelial cell lines.

Alfonso-De Matte MY, Cheng JQ, Kruk PA.

Exp Cell Res. 2001 Jul 1;267(1):13-27.

PMID:
11412034
33.
34.

Telomeric length in individuals and cell lines with altered p53 status.

Kruk PA, Bohr VA.

Radiat Oncol Investig. 1999;7(1):13-21.

PMID:
10030619
35.

Telomerase activity is elevated in early S phase in hamster cells.

Kruk PA, Orren DK, Bohr VA.

Biochem Biophys Res Commun. 1997 Apr 28;233(3):717-22.

PMID:
9168921
36.

Telomere reduction and telomerase inactivation during neuronal cell differentiation.

Kruk PA, Balajee AS, Rao KS, Bohr VA.

Biochem Biophys Res Commun. 1996 Jul 16;224(2):487-92.

PMID:
8702416
37.

DNA damage and repair in telomeres: relation to aging.

Kruk PA, Rampino NJ, Bohr VA.

Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):258-62.

38.

Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix.

Kruk PA, Uitto VJ, Firth JD, Dedhar S, Auersperg N.

Exp Cell Res. 1994 Nov;215(1):97-108.

PMID:
7525326
39.

Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes.

Auersperg N, Maines-Bandiera SL, Dyck HG, Kruk PA.

Lab Invest. 1994 Oct;71(4):510-8.

PMID:
7967506
40.

A line of rat ovarian surface epithelium provides a continuous source of complex extracellular matrix.

Kruk PA, Auersperg N.

In Vitro Cell Dev Biol Anim. 1994 Apr;30A(4):217-25.

PMID:
8069444
41.

Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix.

Kruk PA, Auersperg N.

Am J Obstet Gynecol. 1992 Nov;167(5):1437-43.

PMID:
1443002
42.
43.

Percoll centrifugation eliminates mold contaminants from cell cultures.

Kruk PA, Auersperg N.

In Vitro Cell Dev Biol. 1991 Apr;27A(4):273-6. No abstract available.

PMID:
1856152
44.

Ovarian surface epithelium: autonomous production of connective tissue-type extracellular matrix.

Auersperg N, Maclaren IA, Kruk PA.

Biol Reprod. 1991 Apr;44(4):717-24.

PMID:
1710511
45.

A simplified method to culture human ovarian surface epithelium.

Kruk PA, Maines-Bandiera SL, Auersperg N.

Lab Invest. 1990 Jul;63(1):132-6.

PMID:
2374399
46.

Histochemical classification based upon reaction types and its application to carbohydrate histochemistry.

Reid PE, Owen DA, Kruk PA, Maitland ME.

Histochem J. 1990 May;22(5):299-308. Review.

PMID:
2133465

Supplemental Content

Support Center